Sectors & Industries HealthcareHealth Information Services
Best Health Information Service Stocks to Buy Now (2025)
Top health information service stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best health information service stocks to buy now. Learn More.

Industry: Health Information Servic...

Price Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Health Information Services is Zen Rated A and is the 28th ranked industry out of 145 stock market industries

Ticker	Company	Zen Rating	Value	Growth	Momentum	Sentiment	Safety	Financials	AI	1w Zen Rating	1m Zen Rating	3m Zen Rating	1y Zen Rating
TBRG	TRUBRIDGE INC	A	B	B	C	C	C	B	C	A	A	A	C
BTSG	BRIGHTSPRING HEALTH SERVICES INC	B	C	A	C	B	B	C	C	A	B	B	C
OPRX	OPTIMIZERX CORP	B	C	A	B	C	C	B	D	B	B	B	C
DH	DEFINITIVE HEALTHCARE CORP	B	B	B	C	B	C	C	C	B	B	B	C
TXG	10X GENOMICS INC	B	C	A	C	B	C	B	B	B	B	C	C

Upgrade to Premium to View More

Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More

Already have access to Premium?

Health Information Service Stocks FAQ

What are the best health information service stocks to buy right now in Nov 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best health information service stocks to buy right now are:

1. Trubridge (NASDAQ:TBRG)

Trubridge (NASDAQ:TBRG) is the #1 top health information service stock out of 55 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Trubridge (NASDAQ:TBRG) is: Value: B, Growth: B, Momentum: C, Sentiment: C, Safety: C, Financials: B, and AI: C.

Trubridge (NASDAQ:TBRG) has a Due Diligence Score of 19, which is -8 points lower than the health information service industry average of 27. Although this number is below the industry average, our proven quant model rates TBRG as a "A".

TBRG passed 7 out of 38 due diligence checks and has weak fundamentals. Trubridge has seen its stock return 43.11% over the past year, overperforming other health information service stocks by 100 percentage points.

2. Brightspring Health Services (NASDAQ:BTSG)

Brightspring Health Services (NASDAQ:BTSG) is the #2 top health information service stock out of 55 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year. Learn more.

The Component Grade breakdown for Brightspring Health Services (NASDAQ:BTSG) is: Value: C, Growth: A, Momentum: C, Sentiment: B, Safety: B, Financials: C, and AI: C.

Brightspring Health Services (NASDAQ:BTSG) has a Due Diligence Score of 28, which is 1 points higher than the health information service industry average of 27.

BTSG passed 9 out of 33 due diligence checks and has average fundamentals. Brightspring Health Services has seen its stock return 75.16% over the past year, overperforming other health information service stocks by 132 percentage points.

Brightspring Health Services has an average 1 year price target of $35.17, an upside of 7.87% from Brightspring Health Services's current stock price of $32.60.

Brightspring Health Services stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Brightspring Health Services, 83.33% have issued a Strong Buy rating, 16.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Optimizerx (NASDAQ:OPRX)

Optimizerx (NASDAQ:OPRX) is the #3 top health information service stock out of 55 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year. Learn more.

The Component Grade breakdown for Optimizerx (NASDAQ:OPRX) is: Value: C, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: D.

Optimizerx (NASDAQ:OPRX) has a Due Diligence Score of 26, which is -1 points lower than the health information service industry average of 27. Although this number is below the industry average, our proven quant model rates OPRX as a "B".

OPRX passed 8 out of 33 due diligence checks and has average fundamentals. Optimizerx has seen its stock return 149.6% over the past year, overperforming other health information service stocks by 206 percentage points.

Optimizerx has an average 1 year price target of $20.50, an upside of 8.24% from Optimizerx's current stock price of $18.94.

Optimizerx stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Optimizerx, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the health information service stocks with highest dividends?

Out of 6 health information service stocks that have issued dividends in the past year, the 3 health information service stocks with the highest dividend yields are:

1. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 9.41%, which is 7 percentage points higher than the health information service industry average of 2.65%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. Premier (NASDAQ:PINC)

Premier (NASDAQ:PINC) has an annual dividend yield of 2.99%, which is the same as the health information service industry average of 2.65%. Premier's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Premier's dividend has shown consistent growth over the last 10 years.

Premier's dividend payout ratio of -289.7% indicates that its dividend yield might not be sustainable for the long-term.

3. National Research (NASDAQ:NRC)

National Research (NASDAQ:NRC) has an annual dividend yield of 2.51%, which is the same as the health information service industry average of 2.65%. National Research's dividend payout is not stable, having dropped more than 10% four times in the last 10 years. National Research's dividend has not shown consistent growth over the last 10 years.

National Research's dividend payout ratio of 46.2% indicates that its dividend yield is sustainable for the long-term.

Why are health information service stocks down?

Health information service stocks were down -2.64% in the last day, and down -1.91% over the last week. Evolent Health was the among the top losers in the health information services industry, dropping -17.33% yesterday.

Evolent Health shares are trading higher after the company reported better-than-expected Q3 sales results and raised its FY25 sales guidance.

What are the most undervalued health information service stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued health information service stocks right now are:

1. Goodrx Holdings (NASDAQ:GDRX)

Goodrx Holdings (NASDAQ:GDRX) is the most undervalued health information service stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Goodrx Holdings has a valuation score of 86, which is 67 points higher than the health information service industry average of 19. It passed 6 out of 7 valuation due diligence checks.

Goodrx Holdings's stock has dropped -38.29% in the past year. It has overperformed other stocks in the health information service industry by 18 percentage points.

2. Solventum (NYSE:SOLV)

Solventum (NYSE:SOLV) is the second most undervalued health information service stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Solventum has a valuation score of 43, which is 24 points higher than the health information service industry average of 19. It passed 3 out of 7 valuation due diligence checks.

Solventum's stock has dropped -4.73% in the past year. It has overperformed other stocks in the health information service industry by 52 percentage points.

3. Ge Healthcare Technologies (NASDAQ:GEHC)

Ge Healthcare Technologies (NASDAQ:GEHC) is the third most undervalued health information service stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ge Healthcare Technologies has a valuation score of 43, which is 24 points higher than the health information service industry average of 19. It passed 3 out of 7 valuation due diligence checks.

Ge Healthcare Technologies's stock has dropped -17.3% in the past year. It has overperformed other stocks in the health information service industry by 39 percentage points.

Are health information service stocks a good buy now?

56.76% of health information service stocks rated by analysts are a strong buy right now. On average, analysts expect health information service stocks to rise by 28.69% over the next year.

2.27% of health information service stocks have a Zen Rating of A (Strong Buy), 34.09% of health information service stocks are rated B (Buy), 54.55% are rated C (Hold), 6.82% are rated D (Sell), and 2.27% are rated F (Strong Sell).

What is the average p/e ratio of the health information services industry?

The average P/E ratio of the health information services industry is 44.45x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.